ACTU · Actuate Therapeutics, Inc.
$1.66
-0.04 (-2.07%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$39.74M
Shares
24.01M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-03-10 | The Citizens Life Sciences Conference | Conference |
| 2025-05-31 | Actuate Therapeutics Investor Event at ASCO to Discuss Elraglusib Phase 2 Topline Data in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | Event |
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
52 filings
52 filers
Visit website
Investor relations